Clinical trial
Efficacy and Safety of the Application of Pulsed Radiofrequency, Combined With Platelet Rich Plasma, to the Treatment of Idiopathic Glossopharyngeal Neuralgia (GPN): A Study Protocol for a Multi-Center, Prospective, Open-Label, Propensity Score Match Cohort Study
NCT06931457 is registered in ClinicalTrials.gov with Beijing Tiantan Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy and Safety of the Application of Pulsed Radiofrequency, Combined With Platelet Rich Plasma, to the Treatment of Idiopathic Glossopharyngeal Neuralgia (GPN): A Study Protocol for a Multi-Center, Prospective, Open-Label, Propensity Score Match Cohort Study
- Lead sponsor
- Beijing Tiantan Hospital
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- May 1, 2025
- Completion date
- June 1, 2027
- Enrollment
- 121 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
glossopharyngeal neuralgia, platelet rich plasma, pulsed radiofrequency